Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables - Fees: 2019-2024

  • HUTCHMED (China)'s Receivables - Fees rose 9.76% to $675,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $675,000, marking a year-over-year increase of 9.76%. This contributed to the annual value of $675,000 for FY2024, which is 9.76% up from last year.
  • As of Q4 2024, HUTCHMED (China)'s Receivables - Fees stood at $675,000, which was up 9.76% from $615,000 recorded in Q4 2023.
  • In the past 5 years, HUTCHMED (China)'s Receivables - Fees ranged from a high of $883,000 in Q4 2021 and a low of $615,000 during Q4 2023.
  • Moreover, its 3-year median value for Receivables - Fees was $675,000 (2024), whereas its average is $657,667.
  • Its Receivables - Fees has fluctuated over the past 5 years, first fell by 22.65% in 2022, then climbed by 9.76% in 2024.
  • Over the past 5 years, HUTCHMED (China)'s Receivables - Fees (Quarterly) stood at $848,000 in 2020, then increased by 4.13% to $883,000 in 2021, then declined by 22.65% to $683,000 in 2022, then fell by 9.96% to $615,000 in 2023, then climbed by 9.76% to $675,000 in 2024.
  • Its Receivables - Fees was $675,000 in Q4 2024, compared to $615,000 in Q4 2023 and $683,000 in Q4 2022.